Barclays’s Elanco Animal Health ELAN Stock Holding History

Barclays’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30,000	Closed	-$488K	–	4990
2024 Q1	$488K	Hold	30,000	–	–	﹤0.01%	3610
2023 Q4	$447K	Buy	+30,000	New	+$340K	﹤0.01%	3948
2021 Q1	–	Sell	-6,100	Closed	-$187K	–	4818
2020 Q4	$187K	Hold	6,100	–	–	﹤0.01%	3795
2020 Q3	$170K	Sell	6,100 -27,400	-82%	-$694K	﹤0.01%	3943
2020 Q2	$719K	Sell	33,500 -29,800	-47%	-$658K	﹤0.01%	3043
2020 Q1	$1.42M	Buy	63,300 +20,600	+48%	+$564K	﹤0.01%	2607
2019 Q4	$1.26M	Sell	42,700 -25,100	-37%	-$682K	﹤0.01%	3463
2019 Q3	$1.8M	Buy	67,800 +67,600	+33,800%	+$2.03M	﹤0.01%	3000
2019 Q2	$7K	Buy	+200	New	+$6.49K	﹤0.01%	6628

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Barclays's ELAN Position: Q1 2026 in Review

Barclays reduced its Elanco Animal Health (ELAN) stake by 35% in Q1 2026, selling an estimated $3.52M and leaving 267,582 shares worth $6.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

Barclays first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $29M in Q3 2021. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Barclays held 267,582 shares of Elanco Animal Health worth $6.4M as of Q1 2026.
Barclays sold 143,903 Elanco Animal Health shares in Q1 2026, an estimated $3.52M.
Elanco Animal Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1674 holding.
Barclays first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
Barclays's Elanco Animal Health position peaked at $29M in Q3 2021.
516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.